FDA product code OAM

Immunoassay, Insulin-Like Growth Factor Binding Protein-1

Clinical Chemistry·Class 1·21 CFR 862.1550
US regulatory classifications
US Product Code (FDA)
OAM
View Product Code Classification →
US Risk Class (FDA)
Class 1
US Regulation (CFR)
21 CFR 862.1550
View CFR Regulation →
Medical specialty
Clinical Chemistry
Device characteristics
GMP exempt
No
Implantable
No
Life-sustaining
No
Third party review
Not Eligible
Definition

The device is a qualitative immunochromatographic test for the detection of amniotic fluid in cervicovaginal secretions. The test is intended for professional use to help diagnose the rupture of fetal membranes in pregnant women.

Search keywords

Click to search for similar devices in our global database

About this record

Immunoassay, Insulin-Like Growth Factor Binding Protein-1 is a medical device type in the Clinical Chemistry specialty. This page includes real-world medical device registration data worldwide for this device type, with registrations from US FDA, Brazil ANVISA, and other global markets.

View regulatory classifications, recent 510(k) clearances, active device registrations, and similar products registered globally under this device category. Pure Global AI's free directory provides comprehensive worldwide registration intelligence across 7,000+ medical device types and 21 specialties.